Imperial researchers investigating medical cannabis for cancer and acute pain
Imperial College London researchers are trialling cannabis-based medicinal products for the treatment of cancer and acute pain.
Antibiotics reduce survival rates in cancer patients taking immunotherapy
Cancer patients on immunotherapy fare worse if they have recently taken antibiotics, with their response and overall survival rate ‘crashing’.
1
Colour-change urine test for cancer shows potential in mouse study
A simple and sensitive urine test developed by Imperial and MIT engineers has produced a colour change in urine to signal growing tumours in mice.
Breast cancer can form ‘sleeper cells’ after drug treatment
Breast cancer medicines may force some cancer cells into ‘sleeper mode’, allowing them to potentially come back to life years after initial treatment.
Chemical imaging used to diagnose colon cancer
Researchers have developed a method of chemical imaging which identifies colon cancer more accurately and efficiently than traditional methods.
EDEN2020 performs the very first live flexible needle insertion
EU-funded Horizon2020 research project, EDEN2020 performs first flexible catheter insertion
£13m Convergence Science Centre to 'secure the future' of people with cancer
The Cancer Research UK Convergence Science Centre at The Institute of Cancer Research and Imperial College London was announced today.
Celebrating ten years of brain tumour research excellence at Imperial
The John Fulcher Molecular Neuro-Oncology Lab has established itself as an international centre of excellence for brain tumour research.
Smartphone network helps uncover hundreds of anti-cancer molecules in our food
A crowdsourcing project which uses thousands of idling smartphones has helped to uncover anti-cancer properties of everyday foods and medicines.
Imperial academics awarded top honours by the Queen
Planetary scientist Professor David Southwood has been awarded a CBE while molecular pathologist Professor Gerry Thomas has been awarded an OBE.
3
